KCNQ2 Gene Early infantile epileptic encephalopathy type 7 Genetic Test
At DNA Labs UAE, we offer the KCNQ2 Gene Early infantile epileptic encephalopathy type 7 Genetic Test at a cost of AED 4400.0.
Test Components and Details
- Test Name: KCNQ2 Gene Early infantile epileptic encephalopathy type 7 Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Before undergoing the KCNQ2 Gene Early infantile epileptic encephalopathy type 7 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with KCNQ2 Gene Early infantile epileptic encephalopathy type 7.
About KCNQ2 Gene Early infantile epileptic encephalopathy type 7
KCNQ2 gene is associated with Early Infantile Epileptic Encephalopathy Type 7 (EIEE7), a rare genetic disorder that causes seizures and developmental delays in infants. The KCNQ2 gene plays a crucial role in regulating the flow of charged particles into cells, especially in the brain where it controls the activity of nerve cells.
NGS Genetic Testing
The NGS Genetic Test is a type of genetic testing that utilizes Next-Generation Sequencing technology to analyze multiple genes simultaneously. In the case of KCNQ2 Gene Early infantile epileptic encephalopathy type 7, this test can detect mutations in the KCNQ2 gene that may be responsible for the disorder.
The test involves taking a sample of DNA from the patient’s blood or saliva and sequencing the DNA to identify any changes in the KCNQ2 gene. If a mutation is found, it can help confirm a diagnosis of EIEE7 and guide treatment decisions.
Treatment and Genetic Counseling
Treatment for EIEE7 typically involves medications to control seizures and therapies to support development and improve the quality of life. Genetic testing can also provide important information for family planning and genetic counseling.
| Test Name | KCNQ2 Gene Early infantile epileptic encephalopathy type 7 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for KCNQ2 Gene Early infantile epileptic encephalopathy type 7 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNQ2 Gene Early infantile epileptic encephalopathy type 7 |
| Test Details |
KCNQ2 gene is associated with Early Infantile Epileptic Encephalopathy Type 7 (EIEE7). This is a rare genetic disorder that causes seizures and developmental delays in infants. The KCNQ2 gene provides instructions for making a protein that helps regulate the flow of charged particles (ions) into cells. This protein is particularly important in the brain, where it helps control the activity of nerve cells. NGS Genetic Test is a type of genetic testing that uses Next-Generation Sequencing technology to analyze multiple genes at once. This test can detect mutations in the KCNQ2 gene that may be responsible for EIEE7. The test involves taking a sample of DNA from the patient’s blood or saliva and sequencing the DNA to look for changes in the KCNQ2 gene. If a mutation is found in the KCNQ2 gene, it can help confirm a diagnosis of EIEE7 and guide treatment decisions. Treatment for EIEE7 typically involves medications to control seizures and therapies to support development and improve quality of life. Genetic testing can also provide important information for family planning and genetic counseling. |
